Overview
Smart money at a glance
Filings to Sep 26, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: both buying and selling, $136K to $390K in total in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- $136K to $390K tradedMixed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 4 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- 10+ awardsAwards on record
Key stats
Fundamentals Sep 25- Open
- $25.39
- 52-wk high
- $28.75
- High
- $25.44
- 52-wk low
- $19.63
- Low
- $25.22
- Prev close
- $25.45
- Mkt cap
- $174.39B
- P/E
- 8.3x
- Volume
- 22.92M
- Fwd P/E
- 9.9x
- Beta
- 0.43
- Div yield
- 4.39%
- P/S
- 1.4x
- P/B
- 1.6x
- Profit margin
- +16.9%
- Op margin
- +24.8%
- ROE
- +18.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about T filings
Are insiders buying or selling AT&T Inc. (T) stock?
Neither. AT&T Inc. (T) insiders filed no open-market purchases or sales in the 90 days to Sep 26, 2026, according to SEC Form 4 filings.
Which members of Congress have traded T recently?
Rep. Tim Moore (R) sold $50K to $100K on Aug 14, 2026, disclosed 6 days later. Sen. Gary C Peters (D) bought $1K to $15K on Jun 29, 2026, disclosed 3 days later. Rep. David J. Taylor (R) bought $1K to $15K on Jun 5, 2026, disclosed 7 days later. Rep. Tim Moore (R) bought $50K to $100K on Jun 4, 2026, disclosed 1 day later. In total, 4 members disclosed 10 T trades with trade dates in the last 180 days, filed a median 10 days after trading.
How current is this T smart-money data?
This summary uses filings available on Sep 26, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (3)
- CI

Citadel
$158.8M
added
- BA

Balyasny
$75.9M
added
- P7

Point72
$51.4M
added
What Congress is doing
Sells (1)
How top traders are positioned
No tracked top-trader positions in T right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 10.2% above what analysts expected.
Earnings per share
$0.59 expected
Reports Oct 21, 2026, in 25 days
Estimates as of Sep 26, 2026
EPS expected
$0.56 to $0.64
Revenue expected
18 analysts
Last 30 days
Split both ways
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $30.71B | $33.47B | $31.51B | $31.56B |
| Cost of what it sold | $11.82B | $20.28B | $12.57B | $12.05B |
| Gross profit | $18.89B | $13.19B | $18.94B | $19.51B |
| What it spent | ||||
| Sales and admin | $7.45B | $7.40B | $7.32B | $7.22B |
| Other operating costs | $5.32B | $20.28B | $4.97B | $5.25B |
| Total operating expenses | $12.77B | $27.67B | $12.28B | $12.47B |
| What was left | ||||
| Operating profit | $6.12B | $5.16B | $6.66B | $7.04B |
| Interest on debt | $1.70B | $1.83B | $1.81B | $1.88B |
| Profit before tax | $10.65B | $4.26B | $5.40B | $5.82B |
| Tax | $976.0M | $109.0M | $1.18B | $784.0M |
| Net profit | $9.31B | $3.72B | $3.83B | $4.63B |
| EBITDA | $17.67B | $11.22B | $12.18B | $12.67B |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
AT&T stock heads into the open after a 1.38 percent drop
NeutralSep 23GE HealthCare names AT&T CFO Pascal Desroches to board effective Jan. 4, 2027
NeutralSep 22AT&T (T) Stock Moves -1.38%: What You Should Know
NeutralSep 22GE Healthcare Appoints AT&T CFO Pascal Desroches to Board
NeutralSep 22GE Healthcare Technologies Inc. Declares Cash Dividend for the Third Quarter of 2026, Payable on November 13, 2026
Leans bullishSep 22AT&T stock closes higher at the close
Leans bullishSep 22GE Healthcare Technologies Inc. Announces Appointment of Pascal Desroches to Board of Directors, Effective January 4, 2027
NeutralSep 22AT&T CFO to join GE HealthCare (Nasdaq: GEHC) board in 2027
NeutralSep 22
Macro
23 macro signals shaping T right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results